303 related articles for article (PubMed ID: 9851670)
1. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
Matoba H; Sugano S; Yamaguchi N; Miyachi Y
Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
[TBL] [Abstract][Full Text] [Related]
2. Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein.
Lazzereschi D; Ranieri A; Mincione G; Taccogna S; Nardi F; Colletta G
Cancer Res; 1997 May; 57(10):2071-6. PubMed ID: 9158007
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
6. Role of transforming growth factor-beta in transdifferentiation and fibrosis of lens epithelial cells.
Lee EH; Joo CK
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2025-32. PubMed ID: 10440257
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of transforming growth factor-beta type II receptor stimulates embryonic mouse lung branching morphogenesis in culture.
Zhao J; Bu D; Lee M; Slavkin HC; Hall FL; Warburton D
Dev Biol; 1996 Nov; 180(1):242-57. PubMed ID: 8948588
[TBL] [Abstract][Full Text] [Related]
10. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis.
Taketazu F; Kato M; Gobl A; Ichijo H; ten Dijke P; Itoh J; Kyogoku M; Rönnelid J; Miyazono K; Heldin CH
Lab Invest; 1994 May; 70(5):620-30. PubMed ID: 8196359
[TBL] [Abstract][Full Text] [Related]
12. Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition.
Nishikawa Y; Wang M; Carr BI
J Cell Physiol; 1998 Sep; 176(3):612-23. PubMed ID: 9699514
[TBL] [Abstract][Full Text] [Related]
13. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
Ripley D; Tang XM; Ma C; Chegini N
Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
[TBL] [Abstract][Full Text] [Related]
14. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
Yoshizawa M; Miyazaki H; Kojima S
J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
Okamoto M; Oyasu R
Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
17. Expression of TGF beta1 genes and their receptor types I, II, and III in low- and high-grade malignancy non-Hodgkin's lymphomas.
Woszczyk D; Gola J; Jurzak M; Mazurek U; Mykała-Cieśla J; Wilczok T
Med Sci Monit; 2004 Jan; 10(1):CR33-7. PubMed ID: 14704634
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
[TBL] [Abstract][Full Text] [Related]
19. Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats.
Roulot D; Sevcsik AM; Coste T; Strosberg AD; Marullo S
Hepatology; 1999 Jun; 29(6):1730-8. PubMed ID: 10347115
[TBL] [Abstract][Full Text] [Related]
20. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]